Chemical Compound

Tofacitinib

CAS Registry Number 477600-75-2

Back to search Request a Quote

Primary Record

Tofacitinib

In stock: 6,318 g
Purity: 98.9 %
CAS: 477600-75-2

Compound Identifiers & Properties

CAS: 477600-75-2
PubChem CID: 9926791
SMILES: C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N
Canonical SMILES: C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12

Names & Synonyms

Tofacitinib
Tasocitinib
477600-75-2
rac-Tofacitinib
tofacitinibum
Xeljanz
Tofacitinib citrate
Tofactinib
Tedalinab
Tofacitinib?
racemic-tofacitinib
racemic-Tasocitinib
Tofacitinib Base
Cp-690 free base
CP-690550
3eyg
3fup
3lxk
4oti
Tofacitinib [USAN]
Xeljanz (TN)
CP 690550
Tofacitinib (USAN)
(+)-TOFACITINIB
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
RefChem:6313
Tofacitinib (Standard)
Tofacitinib [USAN:INN]
TOFACITINIB [MI]
TOFACITINIB [INN]
D0EG1I
D0O2KL
C16H20N6O
TOFACITINIB [VANDF]
UNII-87LA6FU830
JAK inhibitors: tofacitinib
CHEMBL221959
87LA6FU830
CP-690550 FREE BASE
Tofacitinib (CP-690550,Tasocitinib)
TOFACITINIB [WHO-DD]
cc-396
CHEBI:71200
CP-690550(Tasocitinib)
CP-690,550 FREE BASE
SCHEMBL322753
1259404-17-5
CP-690,550
DTXSID90197271
MFCD11035919
Tofacitinib (CP-690550)
GTPL5677
orb1300872
QCR-53
CP690550
SCHEMBL29351183
CTK3J8304
HSDB 8311
477600-75-2 (free base)
AMY3992
DTXCID00119762
EX-A205
L04AA29
CP-690
MFCD11616529
MFCD22628813
UJLAWZDWDVHWOW-YPMHNXCESA-N
BCPP000274
GLXC-90307
AOB87470
KS-000001IG
KS-000006RA
ZINC3818808
CP690,550
ABP000824
ANW-51607
BDBM50193995
EBC-11351
GRC-10693
HY-40354R
NSC782351
NSC800953
s2789
Tofacitinib, 99% - 10MG 10mg
CP-690-550
AKOS005145814
AKOS005258733
AC-8193
ACN-031566
AT43433
BCP9000550
CA10005
CC-1770
CCG-264998
CID9926791
CS-0050
DB08895
FT32555
GS-6106
NSC-782351
NSC-800953
RL03781
SDCCGSBI-0654407.P002
CID 9926791
NCGC00229511-02
NCGC00229511-04
NCGC00229511-10
NCGC00229511-25
NCGC00244463-01
Tofacitinib (CP-690550, Tasocitinib)
AJ-45724
BC660087
CP690550(Tasocitinib)/CP-690550
HY-40354
SC-21829
3-((3R,4R)-rel-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
AB0007916
TR-009964
TX-016530
A4138
A7301
NS00069315
W6440
3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile
CP- 690 550
J2.740.060D
D09970
Q-9324
AB01565786_02
EN300-1718468
600M752
AR-270/43507983
Q3530324
BRD-K31283835-001-01-9
BRD-K31283835-048-04-4
3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyr
B0084-453466
1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-, (3R,4R)-
3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo(2,3-d)pyrimidin-4-yl-, (3R,4R)-
212143-23-2
3-(4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
3-[(3R*,4R*)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidyl]-3-oxo-propanenitrile
3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
3-((3R,4R)-4-Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yi)Amino)Piperidin-1-Yl-3-Oxopropaneni
(3R)-beta-Oxo-3alpha-[7H-pyrrolo[2,3-d]pyrimidine-4-yl(methyl)amino]-4alpha-methylpiperidine-1-propanenitrile
(3R,4R)-1-(Cyanoacetyl)-4,N-dimethyl-N-(1H-pyrrolo[2,3-d]pyrimidine-4-yl)-3-piperidineamine
(3R,4R)-3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidine propanenitrile
(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile
(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino]-beta-oxo-1-piperidinepropanenitrile
1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)-
1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-|A-oxo-, (3R,4R)-
3-((3R,4R)-4-methyl-3-(methyl((7H-pyrrolo(2,3-d)pyrimidin-4-yl))amino)piperidin-1-yl)-3-oxopropanenitrile
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitr
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile citrate
3-[(3R,4R)-4-Methyl-3-[N-methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino]piperidine-1-yl]-3-oxopropanenitrile
3-[3alpha-[Methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino]-4alpha-methylpiperidino]-3-oxopropionitrile
3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]piperidin-1-yl}-3-oxo-propionitrile
3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile
3-{4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile
540737-29-9
689-145-4
916591-01-0
937669-80-2
dichloro[(r)-(+)-2,2-bis(diphenylphosphino)-1,1-binaphthyl][(1r,2r)-(+)-1,2-diphenylethylenediamine]
dichloro[(r)-(+)-2,2-bis(diphenylphosphino)-1,1-binaphthyl][(1r,2r)-(+)-1,2-diphenylethylenediamine]ruthenium(ii)
MI1
N-Methyl-N-[(3R)-1-(cyanoacetyl)-4alpha-methylpiperidine-3alpha-yl]-7H-pyrrolo[2,3-d]pyrimidine-4-amine
REL-3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXOPROPANENITRILE
Tofacitinib; 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
Tofacitinib;3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile